MedPath

Effect of Intravenous Lignocaine, Dexmedetomidine and their combination on pulse,blood pressure and oxygen saturation during operation, pain after operation and quality of recovery in patients undergoing uterus removal operation by robot

Completed
Conditions
Other specified menopausal and perimenopausal disorders,
Registration Number
CTRI/2019/09/021323
Lead Sponsor
AIIMS RISHIKESH
Brief Summary

This study is an interventional, single blinded, randomized controlled trial comparing the effect of intravenous  Lignocaine, Dexmedetomidine and their combination on itraoperative haemodynamics, postoperative pain and Quality of recovery in patients undergoing Robotic Abdominal Hysterectomy, to be conducted in AIIMS Rishikesh, India over an expected duration 8 months. The primary outcome is to assess postoperative pain as measured by VAS at 4 hours postoperatively The secondary outcome are Time to first bowel sounds and flatus, Intraoperative consumption of propofol, fentanyl, and vecuronium, Post operative fentanyl requirement and QoR15 score on day 1,2 and on the day of discharge.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
120
Inclusion Criteria

1.Female patients aged 30-65 years, 2.ASA grade I & II 3.Patients undergoing elective Robotic Abdominal Hysterectomy under general anaesthesia will be selected.

Exclusion Criteria

1.ASA grade III & IV patients 2.Age >65 years 3.BMI>35kg/m2 4.Allergy to local anaesthetic agents 5.History of use of opioid, analgesics and psychotropic drugs and beta blockers, substance abuse preoperatively 6.Uncontrolled hypertension, A-V conduction block, history of sleep apnoea.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess post operative pain as measured by VAS4 hours after surgery
Secondary Outcome Measures
NameTimeMethod
1.Time to first bowel sounds and flatus2.Intraoperative consumption of propofol, fentanyl and vecuronium

Trial Locations

Locations (1)

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, RISHIKESH

🇮🇳

Dehradun, UTTARANCHAL, India

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, RISHIKESH
🇮🇳Dehradun, UTTARANCHAL, India
Dr PUDI SIVAJI
Principal investigator
9177662720
sivajipudi717@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.